489 related articles for article (PubMed ID: 25524710)
1. Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia.
Radhu N; Garcia Dominguez L; Farzan F; Richter MA; Semeralul MO; Chen R; Fitzgerald PB; Daskalakis ZJ
Brain; 2015 Feb; 138(Pt 2):483-97. PubMed ID: 25524710
[TBL] [Abstract][Full Text] [Related]
2. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.
Farzan F; Barr MS; Levinson AJ; Chen R; Wong W; Fitzgerald PB; Daskalakis ZJ
Brain; 2010 May; 133(Pt 5):1505-14. PubMed ID: 20350936
[TBL] [Abstract][Full Text] [Related]
3. Investigating Cortical Inhibition in First-Degree Relatives and Probands in Schizophrenia.
Radhu N; Dominguez LG; Greenwood TA; Farzan F; Semeralul MO; Richter MA; Kennedy JL; Blumberger DM; Chen R; Fitzgerald PB; Daskalakis ZJ
Sci Rep; 2017 Feb; 7():43629. PubMed ID: 28240740
[TBL] [Abstract][Full Text] [Related]
4. Suppression of gamma-oscillations in the dorsolateral prefrontal cortex following long interval cortical inhibition: a TMS-EEG study.
Farzan F; Barr MS; Wong W; Chen R; Fitzgerald PB; Daskalakis ZJ
Neuropsychopharmacology; 2009 May; 34(6):1543-51. PubMed ID: 19037204
[TBL] [Abstract][Full Text] [Related]
5. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia.
Du X; Choa FS; Chiappelli J; Wisner KM; Wittenberg G; Adhikari B; Bruce H; Rowland LM; Kochunov P; Hong LE
Biol Psychiatry; 2019 Jan; 85(1):49-59. PubMed ID: 30126607
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the relationship between long interval cortical inhibition, working memory and gamma band activity in the dorsolateral prefrontal cortex.
Daskalakis ZJ; Farzan F; Barr MS; Rusjan PM; Favalli G; Levinson AJ; Fitzgerald PB
Clin EEG Neurosci; 2008 Jul; 39(3):150-5. PubMed ID: 18751565
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder.
Kang JI; Kim CH; Namkoong K; Lee CI; Kim SJ
J Clin Psychiatry; 2009 Dec; 70(12):1645-51. PubMed ID: 19709504
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
[TBL] [Abstract][Full Text] [Related]
10. Emotion regulation before and after transcranial magnetic stimulation in obsessive compulsive disorder.
de Wit SJ; van der Werf YD; Mataix-Cols D; Trujillo JP; van Oppen P; Veltman DJ; van den Heuvel OA
Psychol Med; 2015 Oct; 45(14):3059-73. PubMed ID: 26027740
[TBL] [Abstract][Full Text] [Related]
11. Motor cortical excitability in obsessive-compulsive disorder: Transcranial magnetic stimulation study.
Khedr EM; Elbeh KA; Elserogy Y; Khalifa HE; Ahmed MA; Hafez MH; Ali AM; Elfetoh NA
Neurophysiol Clin; 2016 Apr; 46(2):135-43. PubMed ID: 27016878
[TBL] [Abstract][Full Text] [Related]
12. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
13. Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial.
Mansur CG; Myczkowki ML; de Barros Cabral S; Sartorelli Mdo C; Bellini BB; Dias AM; Bernik MA; Marcolin MA
Int J Neuropsychopharmacol; 2011 Nov; 14(10):1389-97. PubMed ID: 21557884
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working Memory.
Lett TA; Kennedy JL; Radhu N; Dominguez LG; Chakravarty MM; Nazeri A; Farzan F; Walter H; Heinz A; Mulsant BH; Daskalakis ZJ; Voineskos AN
Neuropsychopharmacology; 2016 Aug; 41(9):2224-31. PubMed ID: 26822489
[TBL] [Abstract][Full Text] [Related]
15. Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophrenia.
Kaster TS; de Jesus D; Radhu N; Farzan F; Blumberger DM; Rajji TK; Fitzgerald PB; Daskalakis ZJ
Schizophr Res; 2015 Jul; 165(2-3):157-62. PubMed ID: 25957485
[TBL] [Abstract][Full Text] [Related]
16. Cortical inhibition in motor and non-motor regions: a combined TMS-EEG study.
Fitzgerald PB; Daskalakis ZJ; Hoy K; Farzan F; Upton DJ; Cooper NR; Maller JJ
Clin EEG Neurosci; 2008 Jul; 39(3):112-7. PubMed ID: 18751559
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory deficits in the dorsolateral prefrontal cortex in psychopathic offenders.
Hoppenbrouwers SS; De Jesus DR; Stirpe T; Fitzgerald PB; Voineskos AN; Schutter DJ; Daskalakis ZJ
Cortex; 2013 May; 49(5):1377-85. PubMed ID: 22795183
[TBL] [Abstract][Full Text] [Related]
18. Cortical inhibition of distinct mechanisms in the dorsolateral prefrontal cortex is related to working memory performance: a TMS-EEG study.
Rogasch NC; Daskalakis ZJ; Fitzgerald PB
Cortex; 2015 Mar; 64():68-77. PubMed ID: 25461708
[TBL] [Abstract][Full Text] [Related]
19. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients.
Prikryl R; Ustohal L; Kucerova HP; Kasparek T; Jarkovsky J; Hublova V; Vrzalova M; Ceskova E
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():30-5. PubMed ID: 24211840
[TBL] [Abstract][Full Text] [Related]
20. [Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder].
Nauczyciel C; Drapier D
Rev Neurol (Paris); 2012; 168(8-9):655-61. PubMed ID: 22902174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
